Literature DB >> 30253221

Evidence to Decision framework provides a structured "roadmap" for making GRADE guidelines recommendations.

Shelly-Anne Li1, Paul E Alexander2, Tea Reljic3, Adam Cuker4, Robby Nieuwlaat2, Wojtek Wiercioch2, Gordon Guyatt2, Holger J Schünemann2, Benjamin Djulbegovic5.   

Abstract

OBJECTIVES: It is unclear how guidelines panelists discuss and consider factors (criteria) that are formally and not formally included in the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. To describe the use of decision criteria, we explored how panelists adhered to GRADE criteria and sought to identify any emerging non-GRADE criteria when the panelists used the Evidence to Decision (EtD) framework as part of GRADE application. STUDY DESIGN AND
SETTING: We used conventional and summative qualitative analyses to identify themes emerging from face-to-face, panel meeting discussions. Forty-eight members from 12 countries participated in the development of five guidelines for the management of venous thromboembolism by the American Society of Hematology.
RESULTS: Ten themes corresponded to the GRADE approach and represented all panel discussions. Over half (53%) of the total panel discussions concerned the use of research evidence. When evidence was considered sufficient and clear, the decision-making process proved rapid.
CONCLUSION: The GRADE EtD framework provides structure to guidelines panel meetings, and ensures that the panelists consider all established formal GRADE criteria as they decide on the recommendation text, strength, and direction (for or against an intervention). This is the first study assessing the use of GRADE's EtD framework during real-time guidelines development using panel discussions. Given the widespread use of GRADE, this study provides important information for practice recommendations generated when guidelines panels explicitly follow, in a transparent and systematic manner, the structured GRADE EtD framework. By recognizing the extent to which panels discuss and consider GRADE and other (non-GRADE) criteria for producing guideline recommendations, we are one step closer to understanding the decision-making process in panels that use a structured framework such as the GRADE EtD framework.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical practice guidelines; Decision-making; Epidemiology; Evidence to Decision framework; GRADE; group processing

Mesh:

Year:  2018        PMID: 30253221      PMCID: PMC7275375          DOI: 10.1016/j.jclinepi.2018.09.007

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  32 in total

1.  Guidelines International Network: toward international standards for clinical practice guidelines.

Authors:  Amir Qaseem; Frode Forland; Fergus Macbeth; Günter Ollenschläger; Sue Phillips; Philip van der Wees
Journal:  Ann Intern Med       Date:  2012-04-03       Impact factor: 25.391

2.  Acting on imperfect evidence: How much regret are we ready to accept?

Authors:  Benjamin Djulbegovic; Andrew Frohlich; Charles L Bennett
Journal:  J Clin Oncol       Date:  2005-09-06       Impact factor: 44.544

3.  Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.

Authors:  Philipp Dahm; Andrew D Oxman; Benjamin Djulbegovic; Gordon H Guyatt; M Hassan Murad; Laura Amato; Elena Parmelli; Marina Davoli; Rebecca L Morgan; Reem A Mustafa; Shahnaz Sultan; Yngve Falck-Ytter; Elie A Akl; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2017-04-01       Impact factor: 6.437

4.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength.

Authors:  Jeffrey C Andrews; Holger J Schünemann; Andrew D Oxman; Kevin Pottie; Joerg J Meerpohl; Pablo Alonso Coello; David Rind; Victor M Montori; Juan Pablo Brito; Susan Norris; Mahmoud Elbarbary; Piet Post; Mona Nasser; Vijay Shukla; Roman Jaeschke; Jan Brozek; Ben Djulbegovic; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2013-04-06       Impact factor: 6.437

5.  Adding "value" to clinical practice guidelines.

Authors:  James P McCormack; Peter Loewen
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

6.  Improving the use of research evidence in guideline development: introduction.

Authors:  Andrew D Oxman; Atle Fretheim; Holger J Schünemann
Journal:  Health Res Policy Syst       Date:  2006-11-20

7.  Improving the use of research evidence in guideline development: 3. Group composition and consultation process.

Authors:  Atle Fretheim; Holger J Schünemann; Andrew D Oxman
Journal:  Health Res Policy Syst       Date:  2006-11-29

8.  Improving the use of research evidence in guideline development: 5. Group processes.

Authors:  Atle Fretheim; Holger J Schünemann; Andrew D Oxman
Journal:  Health Res Policy Syst       Date:  2006-12-01

9.  Reaching beyond the review of research evidence: a qualitative study of decision making during the development of clinical practice guidelines for disease prevention in healthcare.

Authors:  Linda Richter Sundberg; Rickard Garvare; Monica Elisabeth Nyström
Journal:  BMC Health Serv Res       Date:  2017-05-11       Impact factor: 2.655

10.  Thinking Styles and Regret in Physicians.

Authors:  Mia Djulbegovic; Jason Beckstead; Shira Elqayam; Tea Reljic; Ambuj Kumar; Charles Paidas; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

View more
  10 in total

Review 1.  Structured decision-making drives guidelines panels' recommendations "for" but not "against" health interventions.

Authors:  Benjamin Djulbegovic; Tea Reljic; Shira Elqayam; Adam Cuker; Iztok Hozo; Qi Zhou; Shelly-Anne Li; Paul Alexander; Robby Nieuwlaat; Wojtek Wiercioch; Holger Schünemann; Gordon Guyatt
Journal:  J Clin Epidemiol       Date:  2019-02-16       Impact factor: 6.437

Review 2.  Characteristics and conflicting recommendations of clinical practice guidelines for COVID-19 management in children: A scoping review.

Authors:  Alvaro Quincho-Lopez; Lesly Chávez-Rimache; José Montes-Alvis; Alvaro Taype-Rondan; Giancarlo Alvarado-Gamarra
Journal:  Travel Med Infect Dis       Date:  2022-05-07       Impact factor: 20.441

Review 3.  Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.

Authors:  Giovanni Ostuzzi; Davide Papola; Chiara Gastaldon; Georgios Schoretsanitis; Federico Bertolini; Francesco Amaddeo; Alessandro Cuomo; Robin Emsley; Andrea Fagiolini; Giuseppe Imperadore; Taishiro Kishimoto; Giulia Michencigh; Michela Nosé; Marianna Purgato; Serdar Dursun; Brendon Stubbs; David Taylor; Graham Thornicroft; Philip B Ward; Christoph Hiemke; Christoph U Correll; Corrado Barbui
Journal:  BMC Med       Date:  2020-07-15       Impact factor: 8.775

4.  The systematic use of evidence-based methodologies and technologies enhances shared decision-making in the 2018 International Consensus Conference on Patient Blood Management.

Authors:  Hans Van Remoortel; Kari Aranko; Markus M Mueller; Emmy De Buck; Dana Devine; Gilles Folléa; Patrick Meybohm; Pierre Tiberghien; Erica M Wood; Philippe Vandekerckhove; Erhard Seifried
Journal:  Vox Sang       Date:  2019-11-10       Impact factor: 2.144

5.  Application of evidence-based methods to construct mechanism-driven chemical assessment frameworks.

Authors:  Sebastian Hoffmann; Elisa Aiassa; Michelle Angrish; Claire Beausoleil; Frederic Y Bois; Laura Ciccolallo; Peter S Craig; Rob B M De Vries; Jean Lou C M Dorne; Ingrid L Druwe; Stephen W Edwards; Chantra Eskes; Marios Georgiadis; Thomas Hartung; Aude Kienzler; Elisabeth A Kristjansson; Juleen Lam; Laura Martino; Bette Meek; Rebecca L Morgan; Irene Munoz-Guajardo; Pamela D Noyes; Elena Parmelli; Aldert Piersma; Andrew Rooney; Emily Sena; Kristie Sullivan; José Tarazona; Andrea Terron; Kris Thayer; Jan Turner; Jos Verbeek; Didier Verloo; Mathieu Vinken; Sean Watford; Paul Whaley; Daniele Wikoff; Kate Willett; Katya Tsaioun
Journal:  ALTEX       Date:  2022-03-01       Impact factor: 6.250

6.  Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practice.

Authors:  Nawar Diar Bakerly; Kirill Nikitin; Neil G Snowise; Glenn Cardwell; Daryl Freeman; Ravijyot Saggu; Anthony De Soyza
Journal:  BMJ Open Respir Res       Date:  2022-09

7.  Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Linda Nici; Manoj J Mammen; Edward Charbek; Paul E Alexander; David H Au; Cynthia M Boyd; Gerard J Criner; Gavin C Donaldson; Michael Dreher; Vincent S Fan; Andrea S Gershon; MeiLan K Han; Jerry A Krishnan; Fernando J Martinez; Paula M Meek; Michael Morgan; Michael I Polkey; Milo A Puhan; Mohsen Sadatsafavi; Don D Sin; George R Washko; Jadwiga A Wedzicha; Shawn D Aaron
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

8.  The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline.

Authors:  Bram Rochwerg; Sharon Einav; Dipayan Chaudhuri; Jordi Mancebo; Tommaso Mauri; Yigal Helviz; Ewan C Goligher; Samir Jaber; Jean-Damien Ricard; Nuttapol Rittayamai; Oriol Roca; Massimo Antonelli; Salvatore Maurizio Maggiore; Alexandre Demoule; Carol L Hodgson; Alain Mercat; M Elizabeth Wilcox; David Granton; Dominic Wang; Elie Azoulay; Lamia Ouanes-Besbes; Gilda Cinnella; Michela Rauseo; Carlos Carvalho; Armand Dessap-Mekontso; John Fraser; Jean-Pierre Frat; Charles Gomersall; Giacomo Grasselli; Gonzalo Hernandez; Sameer Jog; Antonio Pesenti; Elisabeth D Riviello; Arthur S Slutsky; Renee D Stapleton; Daniel Talmor; Arnaud W Thille; Laurent Brochard; Karen E A Burns
Journal:  Intensive Care Med       Date:  2020-11-17       Impact factor: 17.440

Review 9.  How to identify, incorporate and report patient preferences in clinical guidelines: A scoping review.

Authors:  Claire Kim; Melissa J Armstrong; Whitney B Berta; Anna R Gagliardi
Journal:  Health Expect       Date:  2020-07-12       Impact factor: 3.377

Review 10.  Evidence-to-decision frameworks: a review and analysis to inform decision-making for environmental health interventions.

Authors:  Susan L Norris; Max T Aung; Nicholas Chartres; Tracey J Woodruff
Journal:  Environ Health       Date:  2021-12-08       Impact factor: 5.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.